Moreover, it supports the possibility of administering multiple doses of MSC, even from different donors, and highlights their therapeutic potential in graft-versus-host disease6 or autoimmune diseases in which CD8 T lymphocytes play an important role.76 The gene discussed is CD8A; the disease is autoimmune disease.